|
Agenda Setting
|
Lack of Data
|
National Governments
|
|
Supranational Organizations
|
|
Civil Society Organizations
|
|
Agricultural Industry
|
|
Pharmaceutical Industry
|
|
Achieving Public Engagement
|
National Governments
|
|
Civil Society Organizations
|
|
Competing Health Priorities
|
National Governments
|
|
Pharmaceutical Industry
|
|
Agreement Formulation
|
Unknown Impact of AMR Control Policies
|
National Governments
|
|
Supranational Organizations
|
|
Civil Society Organizations
|
|
Agricultural Industry
|
|
Pharmaceutical Industry
|
|
Reconciling Mandates, Business Models, and Perspectives of Key Stakeholders
|
National Governments
|
|
Supranational Organizations
|
|
Cost Distribution & Funding
|
National Governments
|
|
Supranational Organizations
|
|
Pharmaceutical Industry
|
|
Agreement Legitimation
|
Lack of Enforcement of International Law
|
National Governments
|
|
Supranational Organizations
|
|
Civil Society Organizations
|
|
Agricultural Industry
|
|
Pharmaceutical Industry
|
|
Enacting Binding Rules on a Global Scale
|
National Governments
|
|
Supranational Organizations
|
|
Fragmentation of Global Health Governance and Initiatives
|
Supranational Organizations
|
|
Agreement Implementation
|
Unregulated Distribution of Antimicrobials (legal and counterfeit)
|
National Governments
|
|
Civil Society Organizations
|
|
Pharmaceutical Industry
|
|
Lack of Capacity and Infrastructure
|
National Governments
|
|
Civil Society Organizations
|
|
Agricultural Industry
|
|
Pharmaceutical Industry
|
|
Reconciling Domestic Political Powers
|
National Governments
|
|
Coordinating Actors
|
National Governments
|
|
Supranational Organizations
|